Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ursula Schmidt-Erfurth

Showing results (1-10 of 516) with videos related to

Pageof 52
Sort By:
Developments in Ophthalmology|December 18, 2004
Nutrition and retinaUrsula Schmidt-Erfurth
Expert Opinion on Drug Safety|December 17, 2009
Clinical safety of ranibizumab in age-related macular degenerationUrsula Schmidt-Erfurth
Die Ophthalmologie|May 1, 2024
[Complement inhibition treatment for geographic atrophy (GA): functional and morphological efficacy and relevant biomarkers in clinical practice]Ursula Schmidt-Erfurth, Sophie Riedl
Klinische Monatsblatter Fur Augenheilkunde|September 16, 2024
Role of Artificial Intelligence in Retinal DiseasesJulia Mai, Ursula Schmidt-Erfurth
Journal of Ophthalmology|July 17, 2010
Diabetic cataract-pathogenesis, epidemiology and treatmentAndreas Pollreisz, Ursula Schmidt-Erfurth
Investigative Ophthalmology & Visual Science|April 26, 2003
Sequence of early vascular events after photodynamic therapyStephan Michels, Ursula Schmidt-Erfurth
Ophthalmology|January 2, 2008
Randomized multicenter trial of more intense and standard early verteporfin treatment of neovascular age-related macular degenerationUrsula Schmidt-Erfurth, Stefan Sacu,
JAMA Ophthalmology|October 5, 2018
Disorganization of Retinal Inner Layers and the Importance of Setting BoundariesUrsula Schmidt-Erfurth, Martin Michl
Therapeutic Advances in Ophthalmology|March 28, 2022
Quantitative assessment of retinal fluid in neovascular age-related macular degeneration under anti-VEGF therapyGregor S Reiter, Ursula Schmidt-Erfurth
American Journal of Ophthalmology|March 28, 2006
Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degenerationAlbert J Augustin, Ursula Schmidt-Erfurth
Pageof 52

Showing results (1-10 of 516) with videos related to

Sort By:
Pageof 52
Developments in Ophthalmology|December 18, 2004
Nutrition and retinaUrsula Schmidt-Erfurth
Expert Opinion on Drug Safety|December 17, 2009
Clinical safety of ranibizumab in age-related macular degenerationUrsula Schmidt-Erfurth
Die Ophthalmologie|May 1, 2024
[Complement inhibition treatment for geographic atrophy (GA): functional and morphological efficacy and relevant biomarkers in clinical practice]Ursula Schmidt-Erfurth, Sophie Riedl
Klinische Monatsblatter Fur Augenheilkunde|September 16, 2024
Role of Artificial Intelligence in Retinal DiseasesJulia Mai, Ursula Schmidt-Erfurth
Journal of Ophthalmology|July 17, 2010
Diabetic cataract-pathogenesis, epidemiology and treatmentAndreas Pollreisz, Ursula Schmidt-Erfurth
Investigative Ophthalmology & Visual Science|April 26, 2003
Sequence of early vascular events after photodynamic therapyStephan Michels, Ursula Schmidt-Erfurth
Ophthalmology|January 2, 2008
Randomized multicenter trial of more intense and standard early verteporfin treatment of neovascular age-related macular degenerationUrsula Schmidt-Erfurth, Stefan Sacu,
JAMA Ophthalmology|October 5, 2018
Disorganization of Retinal Inner Layers and the Importance of Setting BoundariesUrsula Schmidt-Erfurth, Martin Michl
Therapeutic Advances in Ophthalmology|March 28, 2022
Quantitative assessment of retinal fluid in neovascular age-related macular degeneration under anti-VEGF therapyGregor S Reiter, Ursula Schmidt-Erfurth
American Journal of Ophthalmology|March 28, 2006
Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degenerationAlbert J Augustin, Ursula Schmidt-Erfurth
Pageof 52